Development of a new prophylactic vaccine ONCOVITA and UNITHER Pharmaceuticals partner to develop a new prophylactic vaccine based on Measovir® and Euroject® technologies Paris, March 13,... View Article
From early stages of ophthalmic product development Unither’s CDMO supports its customers from early stages of ophthalmic product development Anaïs CASTEX holds a Master’s degree in Formulation... View Article
Ophthalmics at Butantã site, São Paulo Enhancing ophthalmic care: the role of multidose with preservative (MDWP) In ophthalmology, multidose with preservative (MDWP) droppers remain a cost-effective and... View Article
30 year anniversary Press release Unither Pharmaceuticals celebrates 30 years of innovation and expertise November 29, 2023, Paris – Unither Pharmaceuticals, a... View Article
Nanjing’s R&D cell inauguration Unither Pharmaceuticals: Innovation at the heart of R&D Article taken from a speech by Nathalie MASSON, Director of Innovation... View Article
Foundation stone laid for Laboratoire Unither Amiens new building PRESS RELEASE Foundation stone laid for Laboratoire Unither Amiens new building As part of the Foundation Stone Laying Ceremony... View Article
Unither Pharmaceuticals has completed the purchase of the Novartis site located at Butantã, in São Paulo, Brazil. Unither Pharmaceuticals has completed the purchase of the Novartis site located at Butantã, in São Paulo, Brazil. Paris (France), 11/28/2022... View Article
Jean-François Hilaire: newly appointed CEO of Unither Pharmaceuticals Paris (France), November 14, 2022 – Unither Pharmaceuticals’ Supervisory Board appoints Jean-François Hilaire as Chief Executive Officer. As Executive Chairman,... View Article
Laboratoire Unither Coutances inaugurates its new premises and production facilities Coutances (France), September 21, 2022 – Laboratoire Unither Coutances has opened its new production facilities and workshops, acquiring the world’s... View Article
